INTRODUCTION
showed that mice could be immunized by nasal instillation of B. pertussis antigens against respiratory challenge with the homologous organism. North & Anderson (1942) suggested that the immunity obtained by this technique was both a general (circulating) specific immunity and a local respiratory immunity in which non-specific factors played a part. Cooper (1952) reported that intranasal instillation of sublethal doses of live B. pertussis in mice appeared to induce a general and local immunity to challenge but pertussis vaccine given by this route produced only a local immunity to infection. Andersen (1952) suggested that larger doses of pertussis vaccine given intranasally would induce general as well as local respiratory immunity.
Immunoglobulins are known to be present in the respiratory secretions (Tomasi, Tan, Soloman & Prendergast, 1965) and are associated with specific antibody activity (Alford, Rossen, Butler & Kasel, 1967) which is contained almost entirely in the IgA fraction. Most investigations into respiratory immunization have been conducted with influenza vaccine and the results evaluated by epidemiological studies, respiratory secretory antibody response and by live challenge procedures Kasel et al. 1969; Thomas, 1973) . These studies have shown that specific protective antibodies can be induced in respiratory tract secretions by local application of antigens. Holt (1972) restated the suggestions made by North & Anderson thirty years earlier regarding immunity to whooping cough, i.e. there exists a general immunity (involving polymorphs and an opsonin) mobilized by the inflammatory response at the surface 234 GERALD THOMAS of the respiratory mucous membrane and a local prophylactic immunity involving specific secretory IgA antibodies.
The investigations described in this paper are concerned with the variations in antibody concentrations in respiratory secretions after aerosol and intramuscular immunization with B. pertussis vaccine. Holt (1972) attempted to detect antibody to B. pertussis in respiratory secretions and sera from an aerosol-immunized Taiwan monkey, using a tissue culture adsorption-inhibition technique, and obtained very variable results. In the investigations described in this paper a radio-immunoassay technique was used to estimate antibody titre to B. pertussis in respiratory secretions.
MATERIALS AND METHODS

Vaccines
The intramuscular pertussis vaccine contained 4 x 10 10 organisms/ml. (Burroughs Wellcome & Co., London). Respiratory pertussis vaccine was prepared by freezedrying the intramuscular vaccine and was administered by means of a metered dose pressurized aerosol container (3 Ms Laboratories, Loughborough, England).
Respiratory secretions and sera
Respiratory secretions were obtained from eight human volunteers and examined for protein and IgA content as previously described (Thomas, 1973) . Antibody titres in respiratory secretions were examined by passive haemagglutination (Cruickshank, Duguid & Swain, 1965 ) and a radio-immunoassy technique (Restall, Thomas & Pennant, 1973 ) adapted from the method described by Rosenthal, Hayashi & Notkins (1972) . Since the IgA content of the nasal secretion samples (and hence the antibody concentrations) varied considerably from one sample to another a standardization procedure was adopted to make the samples comparable. mu r ii • r 1 J counts/second x 100 The following formula was used -;
. Antibody titres in sera were & IgA content J assayed by the passive haemagglutination method, using the vaccine strain of B. pertussis to coat the sensitized sheep cells.
Immunization and sampling procedures
Six adult volunteers received 3 doses of 0-5 ml. of vaccine intramuscularly at monthly intervals. Serum and respiratory secretion samples were obtained before immunization and 3 weeks after the last dose of vaccine. Eight adult volunteers received one dose of aerosol vaccine inhaled via the nostrils (equivalent to 0-5 ml. of the vaccine given intramuscularly). Serum and respiratory secretion samples were obtained before immunization and 3 weeks after immunization.
RESULTS
Passive haemagglutination
Antibody was not detectable in any of the respiratory secretion samples by this method (nor by slide or tube agglutination) from the two groups of volunteers. Serum antibody to B. pertussis (Table 1) was present in all the samples from both groups. No significant changes were seen in the aerosol post-immunization serum titres while five of the six intramuscular post-immunization titres showed fourfold or greater increases.
Aerosol pertussis vaccine
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Radio-immunoassay B. pertussis antibody was present in all the respiratory secretion samples from both groups (Table 2 ). Significant changes were evident only in the aerosol postimmunization samples. DISCUSSION Serum antibody titres to B. pertussis are frequently relatively low in adults (Kendrick et al. 1969; Abbott, Preston & Mackay, 1971) . Even after several intramuscular injections antibody titres do not rise remarkably (Abbott et al. 1971) . The titres for the intramuscularly immunized volunteers (Table 1 ) are similar to those described by other workers. It is thus not surprising that increases in serum antibody titres were not recorded after aerosol immunization with only a third of the quantity of antigen given to the intramuscularly immunized group.
Detection of antibody to B. pertussis in respiratory secretions required the sensitivity of the radio-immunoassay technique. The results in Table 2 show a reversal of the situation compared with serum antibody. Substantial increases in antibody titre were observed in all of the samples from the aerosol-immunized volunteers, while the intramuscularly immunized group showed only small increases in titre in half of the samples. The numbers involved however are small and similar investigations in larger groups are obviously desirable to verify these observations. Holt (1972) suggested that the antibody present in respiratory secretions acts by inhibiting adhesion of the organism to the cilia of the mucous membrane while the serum antibody has a bactericidal effect exerted when inflammatory changes in the mucous membrane permit transudation of serum proteins. Under these circumstances aerosol immunization (with the dose of antigen given in this investigation) appears to induce only the prophylactic protective mechanism since serum antibody concentrations were unchanged. Larger doses, up to the level of the intramuscular regimen, may however influence serum antibody.
Aerosol immunization against whooping cough cannot at this stage be recommended for use in infants but it may have a place in the protection of adults, especially those exposed to infection such as doctors and nursing staff concerned with paediatric infectious diseases. Outbreaks of whooping cough in adults are known to occur (Editorial, 1968) . Intramuscular immunization of adults is often associated with severe side effects (as was observed during the course of this investigation). Aerosol administration of the B. pertussis antigens was not accompanied by any side effects in the eight volunteers (nor by the author who received four doses by this route). For adults aerosol immunization would be a much preferred method of protection.
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